Intracellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. Learn more
Launch date
Employees
Market cap
$7.9b
Enterprise valuation
$6.9b (Public information from Sep 2024)
Share price
€67.5 23I.F
New York City New York (HQ)
Authorizing premium user...